MissionIR Articles

RXi Pharmaceuticals is a biotech company focused on discovering, developing and commercializing innovative therapies based on its proprietary, next-generation RNAi platform. RXi’s first RNAi product candidate, RXI-109, entered into RXi’s first human clinical trial in…

ERBA Diagnostics is an emerging company in the global healthcare industry, operating in the core business segment of In Vitro Diagnostics (IVD). ERB’s product range includes a wide range of Clinical Chemistry Analyzers (Photometers &…

Viropro, through its subsidiaries, engages in the contract research, development, and manufacturing of biotherapeutic proteins for the treatment of various diseases. The company is also involved in the transfer of its proprietary technologies for industrial…

Addex Therapeutics focuses on the discovery and development of an emerging class of oral small molecule drugs that can be exquisitely selective for their intended target and confer significant therapeutic advantages over conventional “orthosteric” small…

Alliqua is a biomedical company focused on the development, manufacturing and marketing of its own proprietary products based on the company’s existing technology portfolio. ALQA currently markets its own proprietary brands of wound dressings: SilverSeal®…

Cyclacel Pharmaceuticals is a biopharmaceutical company developing oral therapies for the treatment of cancer and other serious diseases. The company has three product candidates are currently in clinical development: Sapacitabine (CYC682) for the treatment of…

MetaStat is a life science company operating through its subsidiary MetaStat BioMedical to develop and commercialize proprietary clinical diagnostic tests that predict the probability of blood borne systemic metastasis of cancer; and therapeutics to prevent…

ImmunoVaccine is a clinical-stage vaccine development company focused on advancing its patented DepoVax™ vaccine adjuvanting platform and product candidates for cancer therapy, infectious diseases and animal health. The company’s pipeline also includes a broad range…

Genmab is a biotech company engaged in the development of human antibody therapeutics for the treatment of cancer in Denmark and internationally. The company has one product on the market, ofatumumab, and is developing a…

Echo Therapeutics is a transdermal medical device company specializing in skin permeation technology. The company is developing its Prelude® SkinPrep System as a platform technology to allow for significantly enhanced and painless skin permeation that…

Ohr Pharmaceutical is engaged in the development of novel therapeutics for the treatment of serious and unmet medical needs. The company’s lead compounds include OHR/AVR 118 for the treatment of cancer cachexia, and Squalamine eye…

Cardium Therapeutics is a health sciences and regenerative medicine company focused on the acquisition and strategic development of new and innovative bio-medical product opportunities and businesses with the potential to address significant unmet medical needs.…

Sernova is a clinical-stage company developing products that provide a natural and immune-protected environment for delivering therapeutic cells to patients. The company is developing two novel closely integrated proprietary platform technologies: Cell Pouch System™ and…

Cipher Pharmaceuticals is a specialty pharmaceutical company that develops improved formulations of existing drugs using drug delivery technologies. The company has three products, all of which are approved by the FDA: Lipofen® for the treatment…

Bavarian Nordic is a vaccine-focused biotech company developing and producing novel vaccines for the treatment and prevention of life-threatening diseases. In oncology, the company’s lead program is PROSTVAC®, a therapeutic vaccine candidate for advanced prostate…

MDxHealth is a molecular diagnostics company that develops and commercializes advanced epigenetic tests to support cancer treatment. The company utilizes its proprietary, patented DNA methylation platform and biomarkers to offer tests that aid in the…

Fluoropharma is engaged in the discovery, development and commercialization of molecular imaging pharmaceuticals with primary applications in the area of cardiology. The company’s BFPET is in phase I trial used for the detection of ischemic…

Bionomics is a drug discovery and development company focused on new treatments for cancer and serious disorders of the central nervous system (CNS). The company utilizes its technology platforms with the aim of identifying and…

Navidea Biopharmaceuticals is a biopharm company focused on the development and commercialization of precision diagnostic agents. NAVB’s radiopharmaceutical development programs include Lymphoseek, a radiopharmaceutical agent for lymph node mapping; AZD4694, an imaging agent; and RIGScan,…

Senesco Technologies is a provider of proven energy efficiency technology for commercial organizations. Sabien’s M2G and M3G products are proven to reduce carbon emissions and energy consumption by between 10% and 25% with typical paybacks…

International Stem Cell, a development-stage biotech company, focuses on the development and commercialization of therapeutic, biomedical and cosmeceutical products based on human parthenogenetic stem cells. It also develops, manufactures and markets anti-aging skin care products.…

Zalicus is a biopharmaceutical company focused on the discovery and development of treatments against pain and immune-inflammatory diseases. The company’s internal pipeline includes Z160 for chronic neuropathic pain and Z944 for acute and inflammatory pain.…

Cryoport provides cold chain frozen shipping systems primarily to the biotechnology, pharmaceutical and life science industries worldwide. CYRX offers reusable cryogenic transport containers for the transportation of biological, environmental and other temperature sensitive materials. The…

Stellar Biotechnologies produces and markets keyhole limpet hemocyanin (KLH), as well as develops technology related to the culture and production of KLH and KLH subunit formulations in the United States and Europe. The company’s KLH…